BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29848105)

  • 1. Glucose-Responsive Microneedle Patches for Diabetes Treatment.
    Chen G; Yu J; Gu Z
    J Diabetes Sci Technol; 2019 Jan; 13(1):41-48. PubMed ID: 29848105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
    GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
    Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy.
    Zhang Y; Wu M; Tan D; Liu Q; Xia R; Chen M; Liu Y; Xue L; Lei Y
    J Mater Chem B; 2021 Jan; 9(3):648-657. PubMed ID: 33306077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patch Pumps for Insulin.
    Ginsberg BH
    J Diabetes Sci Technol; 2019 Jan; 13(1):27-33. PubMed ID: 30070604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.
    Wang J; Ye Y; Yu J; Kahkoska AR; Zhang X; Wang C; Sun W; Corder RD; Chen Z; Khan SA; Buse JB; Gu Z
    ACS Nano; 2018 Mar; 12(3):2466-2473. PubMed ID: 29455516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
    Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.
    Wang J; Wang Z; Yu J; Kahkoska AR; Buse JB; Gu Z
    Adv Mater; 2020 Apr; 32(13):e1902004. PubMed ID: 31423670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
    Yang C; Sheng T; Hou W; Zhang J; Cheng L; Wang H; Liu W; Wang S; Yu X; Zhang Y; Yu J; Gu Z
    Sci Adv; 2022 Dec; 8(48):eadd3197. PubMed ID: 36449622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
    GhavamiNejad A; Lu B; Samarikhalaj M; Liu JF; Mirzaie S; Pereira S; Zhou L; Giacca A; Wu XY
    Drug Deliv Transl Res; 2022 Apr; 12(4):792-804. PubMed ID: 33683625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Pumping Patches: Emerging Insulin Delivery Systems.
    Thompson B; Cook CB
    J Diabetes Sci Technol; 2019 Jan; 13(1):8-10. PubMed ID: 30466305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch Pumps: Are They All the Same?
    Heinemann L; Waldenmaier D; Kulzer B; Ziegler R; Ginsberg B; Freckmann G
    J Diabetes Sci Technol; 2019 Jan; 13(1):34-40. PubMed ID: 30132698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
    Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
    J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
    Wang Z; Wang J; Li H; Yu J; Chen G; Kahkoska AR; Wu V; Zeng Y; Wen D; Miedema JR; Buse JB; Gu Z
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29512-29517. PubMed ID: 33177238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy.
    Chen W; Tian R; Xu C; Yung BC; Wang G; Liu Y; Ni Q; Zhang F; Zhou Z; Wang J; Niu G; Ma Y; Fu L; Chen X
    Nat Commun; 2017 Nov; 8(1):1777. PubMed ID: 29176623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle-based insulin transdermal delivery system: current status and translation challenges.
    Zhao J; Xu G; Yao X; Zhou H; Lyu B; Pei S; Wen P
    Drug Deliv Transl Res; 2022 Oct; 12(10):2403-2427. PubMed ID: 34671948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 18. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
    Yang J; Chen Z; Ye R; Li J; Lin Y; Gao J; Ren L; Liu B; Jiang L
    Drug Deliv; 2018 Nov; 25(1):1728-1739. PubMed ID: 30182757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H
    Hu X; Yu J; Qian C; Lu Y; Kahkoska AR; Xie Z; Jing X; Buse JB; Gu Z
    ACS Nano; 2017 Jan; 11(1):613-620. PubMed ID: 28051306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.